Literature DB >> 9746006

Cognitive deficits associated with frontal-lobe infarction in children with sickle cell disease.

K E Watkins1, D K Hewes, A Connelly, B E Kendall, D P Kingsley, J E Evans, D G Gadian, F Vargha-Khadem, F J Kirkham.   

Abstract

This study examined the cognitive manifestations of frontal-lobe infarction in a population of children with sickle cell disease (SCD). Forty-one patients with SCD underwent MRI. Five patients with stroke symptoms had large infarcts encroaching on the tissue of the frontal lobes. Four patients without symptoms had smaller frontal-lobe infarcts. The patients with stroke were significantly impaired on measures of intelligence, memory, and frontal-lobe function (Wisconsin Card Sorting Test, WCST) compared with both the patients with normal MRI scans (N=30) and a group of sibling controls (N=15), who did not differ from each other. Patients with covert infarction obtained scores on the intelligence tests and the WCST that fell in between those of the stroke patients and the other two groups. This trend toward impairment suggests that patients with covert infarction are at similar risk for cognitive deficits to those with stroke.

Entities:  

Mesh:

Year:  1998        PMID: 9746006     DOI: 10.1111/j.1469-8749.1998.tb15412.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  21 in total

1.  White matter damage in asymptomatic patients with sickle cell anemia: screening with diffusion tensor imaging.

Authors:  B Sun; R C Brown; L Hayes; T G Burns; J Huamani; D J Bearden; R A Jones
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-17       Impact factor: 3.825

2.  Differences in Activation and Deactivation in Children with Sickle Cell Disease Compared with Demographically Matched Controls.

Authors:  B Sun; R C Brown; T G Burns; D Murdaugh; S Palasis; R A Jones
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

3.  Parent education and biologic factors influence on cognition in sickle cell anemia.

Authors:  Allison A King; John J Strouse; Mark J Rodeghier; Bruce E Compas; James F Casella; Robert C McKinstry; Michael J Noetzel; Charles T Quinn; Rebecca Ichord; Michael M Dowling; J Philip Miller; Michael R Debaun
Journal:  Am J Hematol       Date:  2014-02       Impact factor: 10.047

Review 4.  Neuropsychological aspects of pediatric sickle cell disease.

Authors:  M C Kral; R T Brown; G W Hynd
Journal:  Neuropsychol Rev       Date:  2001-12       Impact factor: 7.444

5.  Ameliorating attention problems in children with sickle cell disease: a pilot study of methylphenidate.

Authors:  Brian Daly; Mary C Kral; Ronald T Brown; David Elkin; Avi Madan-Swain; Monica Mitchell; Lori Crosby; David Dematteo; Angela Larosa; Sherron Jackson
Journal:  J Dev Behav Pediatr       Date:  2012-04       Impact factor: 2.225

Review 6.  Targeting pain at its source in sickle cell disease.

Authors:  Kanika Gupta; Om Jahagirdar; Kalpna Gupta
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-28       Impact factor: 3.619

7.  Utility of the Montreal Cognitive Assessment as a Screening Test for Neurocognitive Dysfunction in Adults with Sickle Cell Disease.

Authors:  Cody Cichowitz; Patrick C Carroll; John J Strouse; Carlton Haywood; Sophie Lanzkron
Journal:  South Med J       Date:  2016-09       Impact factor: 0.954

8.  Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition.

Authors:  R Scott Mackin; Philip Insel; Diana Truran; Elliot P Vichinsky; Lynne D Neumayr; F D Armstrong; Jeffrey I Gold; Karen Kesler; Joseph Brewer; Michael W Weiner
Journal:  Neurology       Date:  2014-02-12       Impact factor: 9.910

9.  Stroke in Children with Sickle Cell Disease.

Authors:  Fenella J. Kirkham; Michael R. DeBaun
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

Review 10.  Hypoxia and inflammation in children with sickle cell disease: implications for hippocampal functioning and episodic memory.

Authors:  Mary Iampietro; Tania Giovannetti; Reem Tarazi
Journal:  Neuropsychol Rev       Date:  2014-04-18       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.